Canada markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
28.80-0.75 (-2.54%)
At close: 04:01PM EDT
28.85 +0.05 (+0.17%)
After hours: 05:38PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close29.55
Open29.36
Bid0.00 x 3000
Ask0.00 x 1200
Day's Range28.79 - 29.54
52 Week Range25.20 - 40.37
Volume28,467,725
Avg. Volume39,997,682
Market Cap163.198B
Beta (5Y Monthly)0.64
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.68 (5.69%)
Ex-Dividend DateMay 09, 2024
1y Target EstN/A
  • Yahoo Finance

    Novavax's stock surges almost 300% in the past month

    Novavax stock is soaring on news the FDA set a deadline by which to approve or reject its COVID-19 vaccine.

  • Zacks

    AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug

    The late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with relapsed/refractory multiple myeloma who have received at least two lines of prior therapy.

  • Associated Press Finance

    FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

    Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. Moderna, Pfizer and Novavax all have tested doses updated to match the JN.1 variant that became dominant last winter. FDA’s advisers voted Wednesday that the next vaccine should come from the JN.1 “lineage” or family.